GET DAILY SIGNALSGenworth Financial (GNW) Reports Q3 2026 Loss as Legacy Segment Offsets Enact Strength
Key Takeaways
- Genworth reported a third-quarter 2026 net loss of $41 million, or $0.11 per diluted share, compared with net income of $116 million in the same period a year ago, driven mainly by its legacy Closed Block segment.
- Adjusted operating income excluding Closed Block came in at $102 million, or $0.27 per diluted share, down from $112 million in the prior quarter and $113 million a year earlier.
- Enact, Genworth's mortgage insurance unit, generated $132 million in adjusted operating income, while its PMIERs (Private Mortgage Insurer Eligibility Requirements) sufficiency ratio stayed strong at 158%.
- The company repurchased $80 million of shares and announced a new $500 million repurchase authorization, lifting holding company cash and liquid assets to $320 million.
- The consolidated RBC (risk-based capital) ratio of Genworth's legacy life insurance companies fell to 274% from 303% a year ago.
- CareScout facilitated 1,532 care matches and launched its Care Assurance Worksite product, approved in 40 states as of quarter-end.
Earnings Context and Why It Matters
Genworth Financial operates two distinct businesses: Enact, its majority-owned mortgage insurer, and the Closed Block, a run-off portfolio of legacy long-term care, life, and annuity policies. This structure means quarterly results often reflect two separate narratives rather than one unified performance story. Enact continues to generate capital that supports buybacks and debt reduction, while the Closed Block's outcomes fluctuate with mortality trends, claim utilization, and investment markets. In my view, this report is important because it highlights whether the core capital engine can continue offsetting legacy losses while management maintains a balanced approach to capital allocation.
Reported Results
For the quarter ended September 30, 2026, Genworth recorded a net loss of $41 million, or $0.11 per diluted share, reversing from net income of $47 million in the second quarter and $116 million a year earlier. The loss stemmed primarily from the Closed Block, partially offset by Enact. Adjusted operating income excluding Closed Block, the non-GAAP measure management uses to highlight core performance, reached $102 million, or $0.27 per diluted share, compared with $112 million in the prior quarter and $113 million a year ago. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Enact delivered adjusted operating income of $132 million, down from $143 million in the second quarter, as primary new insurance written declined 7% amid higher mortgage rates. Its loss ratio increased to 20% from 14%, reflecting seasonal rises in new delinquencies and a smaller reserve release than a year earlier. Enact's PMIERs sufficiency ratio held at 158%, about $1.8 billion above requirements. The Closed Block posted an adjusted operating loss of $146 million versus $110 million in the prior quarter, partly due to a $111 million pre-tax actual-versus-expected loss tied to lower terminations and higher long-term care benefit utilization.
Market Reaction and Investor Sentiment
Genworth's results were released after the market close on November 4, 2026, with a conference call set for November 5. The headline net loss largely reflects non-operating volatility in the Closed Block rather than any weakness in the growth engine, a point management has stressed before. Investors will likely balance the drop in the legacy RBC ratio and the larger Closed Block loss against Enact's ongoing capital returns, the fresh $500 million buyback authorization, and improved holding company liquidity. The new repurchase program and $122 million in Enact capital returns indicate management still sees value in its shares and capital position despite headwinds from the run-off book.
Forward Outlook and Key Factors to Monitor
Looking ahead, the key question remains whether Enact's capital generation can keep pace with Closed Block demands while continuing to fund shareholder returns. Enact's new insurance written declined in the quarter as mortgage rates remained elevated, so I’m watching housing market activity, persistency, the loss ratio trajectory, and reserve releases closely.
On the legacy side, the multi-year in-force rate action plan continues as a central lever, with the company estimating roughly $35.0 billion in cumulative net present value benefit since 2012. Future premium increase approvals, benefit reductions, and trends in mortality and long-term care claims will influence Closed Block performance. The RBC ratio also warrants attention after declining on the statutory loss.
CareScout's expansion forms a longer-term story. Management is scaling its aging-care network, and the launch of Care Assurance Worksite represents an initial move into new distribution channels. From what I see, investors will want to track match volume and service revenue progress toward full-year targets without significant widening of Corporate and Other losses.
Using Tickeron AI Tools for Deeper Analysis
I often turn to Tickeron’s AI Screener when evaluating companies like this one. It lets me filter stocks and ETFs by technical patterns, fundamentals, trends, and AI-driven signals to compare opportunities across sectors and identify setups more efficiently than manual methods. This kind of tool helps put quarterly results into broader market context without adding extra layers of complexity.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
GNW sees its Stochastic Oscillator ascends from oversold territory
On October 26, 2026, the Stochastic Oscillator for GNW moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 48 instances where the indicator left the oversold zone. In 38 of the 48 cases the stock moved higher in the following days. This puts the odds of a move higher at over 79%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GNW's RSI Oscillator exited the oversold zone, 19 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on GNW as a result. In 56 of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for GNW just turned positive on October 28, 2026. Looking at past instances where GNW's MACD turned positive, the stock continued to rise in 36 of 48 cases over the following month. The odds of a continued upward trend are 75%.
Following a +2.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where GNW advanced for three days, in 208 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
The Aroon Indicator for GNW entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 11 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: GNW's P/B Ratio (0.391) is slightly lower than the industry average of (1.354). P/E Ratio (17.038) is within average values for comparable stocks, (20.301). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (0.463). Dividend Yield (0.044) settles around the average of (0.047) among similar stocks. P/S Ratio (0.562) is also within normal values, averaging (1.303).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 51 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. GNW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of mortgage insurance products
Industry LifeHealthInsurance